Stock A096760 JW HOLDINGS CORPORATION
Add to a list
To use this feature you must be a member
Log inSign up

Financials JW Holdings Corporation

Equities

A096760

KR7096760004

Pharmaceuticals

End-of-day quote Korea S.E.
Other stock markets
 06:00:00 2024-04-25 pm EDT 		5-day change 1st Jan Change
2,980 KRW -1.00% Intraday chart for JW Holdings Corporation +0.68% -14.61%
Mar. 20 JW (Cayman) Therapeutics Shrinks Loss in Fiscal 2023 MT
Mar. 18 JW Holdings Corporation Reports Earnings Results for the Full Year Ended December 31, 2023 CI

Valuation

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Capitalization 1 459,672 421,046 398,131 235,942 204,970 252,174
Enterprise Value (EV) 1 953,408 889,093 841,156 619,429 594,039 652,258
P/E ratio 19.5 x -12.6 x 44 x -85.5 x 9.25 x 13.2 x
Yield 1.19% 1.42% 1.5% 2.55% 3.36% 2.95%
Capitalization / Revenue 0.63 x 0.58 x 0.51 x 0.3 x 0.24 x 0.27 x
EV / Revenue 1.31 x 1.22 x 1.08 x 0.79 x 0.69 x 0.7 x
EV / EBITDA 14 x 19.8 x 10.5 x 6.16 x 3.94 x 3.47 x
EV / FCF 10.3 x 5.95 x 64.2 x 5.86 x 15.6 x 54.6 x
FCF Yield 9.73% 16.8% 1.56% 17.1% 6.4% 1.83%
Price to Book 2.48 x 2.82 x 3.65 x 2.53 x 1.92 x 2.03 x
Nbr of stocks (in thousands) 73,909 73,904 73,898 72,269 72,262 72,256
Reference price 2 6,219 5,697 5,388 3,265 2,836 3,490
Announcement Date 3/26/19 3/25/20 3/25/21 3/28/22 3/21/23 3/18/24
1KRW in Million2KRW
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net sales 1 725,382 726,424 781,515 788,937 864,536 928,072
EBITDA 1 68,277 44,907 80,239 100,519 150,831 187,887
EBIT 1 33,315 2,736 37,329 62,136 110,705 143,665
Operating Margin 4.59% 0.38% 4.78% 7.88% 12.81% 15.48%
Earnings before Tax (EBT) 1 427.2 -26,082 23,598 32,488 70,995 53,390
Net income 1 23,169 -33,441 9,064 -2,778 22,152 19,026
Net margin 3.19% -4.6% 1.16% -0.35% 2.56% 2.05%
EPS 2 319.8 -452.5 122.4 -38.18 306.5 265.3
Free Cash Flow 1 92,729 149,496 13,107 105,751 38,009 11,944
FCF margin 12.78% 20.58% 1.68% 13.4% 4.4% 1.29%
FCF Conversion (EBITDA) 135.81% 332.9% 16.34% 105.2% 25.2% 6.36%
FCF Conversion (Net income) 400.22% - 144.61% - 171.58% 62.78%
Dividend per Share 2 74.04 80.75 80.75 83.17 95.18 102.9
Announcement Date 3/26/19 3/25/20 3/25/21 3/28/22 3/21/23 3/18/24
1KRW in Million2KRW
Estimates

Balance Sheet Analysis

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net Debt 1 493,735 468,047 443,024 383,486 389,069 400,084
Net Cash position 1 - - - - - -
Leverage (Debt/EBITDA) 7.231 x 10.42 x 5.521 x 3.815 x 2.58 x 2.129 x
Free Cash Flow 1 92,729 149,496 13,107 105,751 38,009 11,944
ROE (net income / shareholders' equity) -1.77% -8.41% 1.03% 1.41% 14.6% 9.1%
ROA (Net income/ Total Assets) 1.59% 0.14% 1.99% 3.56% 6.22% 7.69%
Assets 1 1,459,385 -24,643,215 454,573 -77,958 355,919 247,268
Book Value Per Share 2 2,509 2,024 1,478 1,290 1,481 1,716
Cash Flow per Share 2 1,028 1,566 416.0 649.0 837.0 1,023
Capex 1 23,459 18,851 51,883 37,487 67,628 71,080
Capex / Sales 3.23% 2.6% 6.64% 4.75% 7.82% 7.66%
Announcement Date 3/26/19 3/25/20 3/25/21 3/28/22 3/21/23 3/18/24
1KRW in Million2KRW
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Sector Generic Pharmaceuticals

1st Jan change Capi.
JW HOLDINGS CORPORATION Stock JW Holdings Corporation
-14.61% 156M
SUN PHARMACEUTICAL INDUSTRIES LTD. Stock Sun Pharmaceutical Industries Ltd.
+19.62% 43.34B
OTSUKA HOLDINGS CO., LTD. Stock Otsuka Holdings Co., Ltd.
+20.44% 21.96B
SANDOZ GROUP AG Stock Sandoz Group AG
+10.86% 14.09B
CIPLA LIMITED Stock Cipla Limited
+13.07% 13.64B
ZYDUS LIFESCIENCES LIMITED Stock Zydus Lifesciences Limited
+37.46% 11.43B
ONO PHARMACEUTICAL CO., LTD. Stock Ono Pharmaceutical Co., Ltd.
-8.59% 6.86B
THE MEDICINES COMPANY Stock The Medicines Company
-0.05% 6.79B
STADA ARZNEIMITTEL Stock STADA Arzneimittel
-8.87% 5.73B
ASPEN PHARMACARE HOLDINGS LIMITED Stock Aspen Pharmacare Holdings Limited
+8.46% 5.22B
Generic Pharmaceuticals
  1. Stock Market
  2. Equities
  3. A096760 Stock
  4. Financials JW Holdings Corporation